HBW
BMY icon

Hazlett, Burt & Watson’s Bristol-Myers Squibb BMY Stock Holding History

Hazlett, Burt & Watson’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Buy
5,683
+930
+20% +$53.4K 0.09% 204
2026
Q1 		$287K Hold
4,753
– – 0.09% 208
2025
Q4 		$256K Hold
4,753
– – 0.08% 214
2025
Q3 		$215K Sell
4,753
-1,250
-21% -$58.4K 0.08% 218
2025
Q2 		$277K Sell
6,003
-425
-7% -$20.9K 0.11% 165
2025
Q1 		$392K Sell
6,428
-21
-0.3% -$1.22K 0.18% 121
2024
Q4 		$362K Hold
6,449
– – 0.16% 131
2024
Q3 		$333K Sell
6,449
-374
-5% -$17.5K 0.15% 145
2024
Q2 		$283K Sell
6,823
-100
-1% -$4.47K 0.15% 144
2024
Q1 		$375K Sell
6,923
-1,384
-17% -$70.5K 0.22% 96
2023
Q4 		$425K Sell
8,307
-136
-2% -$7.14K 0.29% 70
2023
Q3 		$489K Buy
8,443
+1
+0% +$61 0.36% 54
2023
Q2 		$537K Buy
8,442
+38
+0.5% +$2.55K 0.4% 48
2023
Q1 		$582K Buy
8,404
+401
+5% +$28.3K 0.48% 38
2022
Q4 		$575K Buy
8,003
+100
+1% +$7.54K 0.51% 37
2022
Q3 		$560K Sell
7,903
-251
-3% -$18.2K 0.54% 36
2022
Q2 		$626K Buy
8,154
+251
+3% +$19.1K 0.57% 36
2022
Q1 		$580K Buy
+7,903
New +$531K 0.46% 45

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hazlett, Burt & Watson's BMY Position: Q2 2026 in Review

Hazlett, Burt & Watson increased its Bristol-Myers Squibb (BMY) stake by 20% in Q2 2026, buying an estimated $53.4K and bringing the position to 5,683 shares worth $329K. The position accounts for 0.09% of the portfolio, ranked #204.

Hazlett, Burt & Watson first reported a position in BMY in Q1 2022 and has held it in 18 quarters since. The position peaked at $626K in Q2 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Hazlett, Burt & Watson held 5,683 shares of Bristol-Myers Squibb worth $329K as of Q2 2026.
  • Hazlett, Burt & Watson bought 930 Bristol-Myers Squibb shares in Q2 2026, an estimated $53.4K.
  • Bristol-Myers Squibb made up 0.09% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #204 holding.
  • Hazlett, Burt & Watson first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 18 quarters since.
  • Hazlett, Burt & Watson's Bristol-Myers Squibb position peaked at $626K in Q2 2022.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.